Status:
COMPLETED
Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
ACADIA Pharmaceuticals Inc.
Conditions:
Parkinson Disease
Parkinson Disease Psychosis
Eligibility:
All Genders
30+ years
Brief Summary
Parkinson's disease psychosis encompasses a range of symptoms, including minor phenomena, frank hallucinations, and delusions. Minor phenomena include passage hallucinations (fleeting sense of a perso...
Eligibility Criteria
Inclusion
- Parkinson's disease (as determined by Movement Disorders Society diagnostic criteria for clinically probable Parkinson's disease)
- Parkinson's disease minor phenomena
- ≥30 years of age
- Proficient in English
- Willing and able to provide informed consent
Exclusion
- Any current or prior history of formed hallucinations or delusions
- Current or prior treatment with an antipsychotic medication (regardless of indication)
- Diagnosis of mania with psychotic features, bipolar or related disorder, depression with psychotic features, or a psychotic disorder
- Unable or unwilling to complete study activities
- Any medical or psychiatric comorbidity that, in the opinion of the investigator, would compromise study participation
Key Trial Info
Start Date :
April 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05240339
Start Date
April 25 2019
End Date
December 31 2023
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642